Citadel Advisors’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,940
| Closed | -$95.8K | – | 6845 |
|
|
2024
Q1 | $95.8K | Buy |
6,940
+3,398
| +96% | +$46.9K | ﹤0.01% | 5096 |
|
|
2023
Q4 | $30.7K | Buy |
+3,542
| New | +$30.7K | ﹤0.01% | 5266 |
|
|
2022
Q3 | – | Sell |
-1,521
| Closed | -$13K | – | 6738 |
|
|
2022
Q2 | $13K | Sell |
1,521
-2,199
| -59% | -$18.8K | ﹤0.01% | 5782 |
|
|
2022
Q1 | $48K | Buy |
+3,720
| New | +$48K | ﹤0.01% | 5920 |
|